Skip to main content
Premium Trial:

Request an Annual Quote

Stokes Institute, GenCell Partner to Develop Thermal Controls for Genetic Testing

NEW YORK (GenomeWeb News) – The University of Limerick's Stokes Institute today announced a collaboration with Irish startup biotech GenCell to develop thermal control solutions for genetic testing technology.

The deal focuses on GenCell's Composite Liquid Cell technology, an approach that simulates nature "by performing molecular biology within synthetic cells," GenCell said on its website, adding the technology provides "the ideal microscale chemical environment for carrying out molecular biology."

GenCell Founder and CEO Kieran Curran said in a statement that the company's products are based on microfluidic or synthetic cells, and GenCell has been addressing challenges such as microfluidic manipulation, biology, and optical interrogation.

"[I]t is critical to maintain close control of temperature to perform genetic reactions important to modern biology," Curran said. "The Stokes Institute offers unrivaled expertise in thermal control techniques, and they also have a deep understanding of the microfluidic phenomena that underpin our technologies.

"GenCell is focused on building a successful Irish biotech company and collaboration with the Stokes Institute definitely delivers a technological edge to help compete better internationally," he continued.

Based in Limerick, Ireland, GenCell has 26 employees.

Financial and other terms of the deal were not disclosed.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.